Lakefront Biotherapeutics GLPGF
NASDAQ GLPGF
$26.24 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (GLPGF) Exchange Rate Effect (2016 - 2026)

Lakefront Biotherapeutics' (GLPGF) quarterly Exchange Rate Effect came in at $819522.0 in Q1 2026, up 159.98% year-over-year from $315228.9 in Q1 2025, and up 152.27% quarter-over-quarter from -$1.6 million in Q4 2025.

Analysis

Lakefront Biotherapeutics (GLPGF) Exchange Rate Effect (2016 - 2026) Analysis & Trends

Lakefront Biotherapeutics (GLPGF) has reported Exchange Rate Effect for 11 consecutive years, with $819522.0 the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Exchange Rate Effect rose 159.98% year-over-year to $819522.0 in Q1 2026; TTM through Mar 2026 was -$2.8 million, a 45519.78% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 361.02% from the prior year.
  • Exchange Rate Effect was $819522.0 for Q1 2026 at Lakefront Biotherapeutics, up from -$1.6 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $18.4 million in Q1 2022 and troughed at -$3.8 million in Q4 2022.
  • A 5-year average of $798144.7 and a median of -$272628.8 in 2023 frame the typical range for Exchange Rate Effect.
  • Across the five-year window, Exchange Rate Effect surged 298.84% in 2024 and plunged 511.86% in 2025, its largest moves.
  • Over 5 years, Exchange Rate Effect stood at -$3.8 million in 2022, then surged by 57.0% to -$1.6 million in 2023, then surged by 186.72% to $1.4 million in 2024, then tumbled by 210.41% to -$1.6 million in 2025, then soared by 152.27% to $819522.0 in 2026.
  • The last three Exchange Rate Effect figures came in at $819522.0 (Q1 2026), -$1.6 million (Q4 2025), and -$100538.7 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn -
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn -300,000.00
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn -
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn 315,000.00
10 Lakefront Biotherapeutics 1.73 Bn 1.73 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 819,521.96
Dec 31, 2025 -1.57 Mn
Sep 30, 2025 -100,538.74
Jun 30, 2025 -1.95 Mn
Mar 31, 2025 -1.37 Mn
Dec 31, 2024 1.42 Mn
Sep 30, 2024 -533,734.68
Jun 30, 2024 473,830.53
Mar 31, 2024 542,094.52
Dec 31, 2023 -1.64 Mn
Mar 31, 2023 -272,628.82
Dec 31, 2022 -3.81 Mn
Mar 31, 2022 18.36 Mn
Jun 30, 2021 -11.60 Mn
Mar 31, 2021 38.30 Mn
Dec 31, 2020 -84.10 Mn
Dec 31, 2019 -11.03 Mn
Jun 30, 2019 -3.49 Mn
Mar 31, 2019 5.65 Mn
Dec 31, 2018 11.51 Bn